CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-29 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −7 | $167.39 | $1K | 253,944 |
| 2025-01-27 | Sheena Jonathan Director | Gift | −588 | 261,157 | ||
| 2025-01-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,442 | $161.87 | $233K | 108,032 |
| 2025-01-24 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −687 | $171.80 | $118K | 109,733 |
| 2025-01-24 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −259 | $172.44 | $45K | 109,474 |
| 2025-01-23 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −495 | $171.09 | $85K | 110,420 |
| 2025-01-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,250 | 110,915 | ||
| 2025-01-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,250 | 3,750 | ||
| 2025-01-22 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −24,799 | $164.95 | $4.1M | 140,746 |
| 2025-01-22 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −62 | $171.95 | $11K | 140,684 |
| 2025-01-22 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −21,175 | $164.95 | $3.5M | 147,283 |
| 2025-01-22 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −53 | $171.96 | $9K | 147,230 |
| 2025-01-22 | Sheena Jonathan Director | Sale 10b5-1 | −964 | $164.95 | $159K | 261,752 |
| 2025-01-22 | Sheena Jonathan Director | Sale 10b5-1 | −7 | $171.91 | $1K | 261,745 |
| 2025-01-22 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −21,985 | $164.95 | $3.6M | 217,847 |
| 2025-01-22 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −54 | $171.95 | $9K | 217,793 |
| 2025-01-22 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −78,359 | $164.95 | $12.9M | 267,823 |
| 2025-01-22 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −194 | $171.97 | $33K | 267,629 |
| 2025-01-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −25,867 | $164.95 | $4.3M | 109,729 |
| 2025-01-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −64 | $171.95 | $11K | 109,665 |
Page 57 of 85 · 1,682 trades